Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / CLASS A COMMON STOCK
-
Shares outstanding
-
118,868,985
-
Total 13F shares
-
113,813,127
-
Share change
-
+8,938,179
-
Total reported value
-
$993,375,835
-
Put/Call ratio
-
69%
-
Price per share
-
$8.73
-
Number of holders
-
269
-
Value change
-
+$50,874,984
-
Number of buys
-
151
-
Number of sells
-
118
Institutional Holders of 10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) as of Q1 2025
As of 31 Mar 2025,
10x Genomics, Inc. - CLASS A COMMON STOCK (TXG) was held by
269 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
113,813,127 shares.
The largest 10 holders included
ARK Investment Management LLC, VANGUARD GROUP INC, FMR LLC, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, BlackRock, Inc., MILLENNIUM MANAGEMENT LLC, Sumitomo Mitsui Trust Group, Inc., Nikko Asset Management Americas, Inc., MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This page lists
271
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.